Z24 Bio converges biology, medicine, engineering, artificial intelligence, and quantum computing to create an ethical, efficient, and precise human-centric platform for drug testing.
FDA NAMs-Aligned
Predictive Toxicology
AI-Driven Analytics
Human-Centric Models
Digital Organ Twins
Quantum-Enhanced Modeling
Patented Technology
Precision Disease Models
Reduced Animal Testing
FDA NAMs-Aligned
Predictive Toxicology
AI-Driven Analytics
Human-Centric Models
Digital Organ Twins
Quantum-Enhanced Modeling
Patented Technology
Precision Disease Models
Reduced Animal Testing
Z24 Bio converges biology, medicine, engineering, artificial intelligence, and quantum computing to create an ethical, efficient, and precise human-centric platform for drug testing.
We believe the future of medicine begins with ethical innovation. Every decision we make — from engineering 3D tissues to developing AI models — is guided by data integrity, reproducibility, and a commitment to replacing animal testing with more human-relevant science.
To replace non-predictive animal tests with scalable human-centric models, enabling safer medicines to reach patients faster and at lower cost
To lead the global transition toward ethical, data-driven, and AI-accelerated drug discovery by creating scalable, human-centric drug testing platform
Founder & CEO
Co-Founder & CTO
Co-Founder & CSO
Chief Adviser
Chief Business Officer
Business Lead
Global Collaborator
Global Collaborator
Research Intern
Research Intern